Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


'Orphan drugs' in search of a home: NEA funds accelerator to fight rare diseases

Venture giant New Enterprise Associates is taking the accelerator concept in a new direction. The firm last week led $16 million in funding for a new accelerator focused on drug development for rare diseases instead of on teams with the code and business pitch for the latest, greatest mobile or web app.

Read More